Ratio of the vitreous vascular endothelial growth factor and pigment epithelial-derived factor in Eales disease (Journal of Ocular Biology, Diseases, and Informatics (2009) DOI 10.1007/s12177-009-9017-7);Ratio of the vitreous vascular endothelial growth factor and pigment epithelial-derived factor in Eales disease

Journal of Ocular Biology, Diseases, and Informatics

Volumn 2, Issue 1, 2009, Pages 20-28

  Angayarkanni, Narayanasamy ^a   Selvi, Radhakrishnan ^a   Pukhraj, Rishi ^b   Biswas, Jyotirmoy ^b   Bhavesh, Shah J ^b   Tombran Tink, Joyce ^c  

^a VISION RESEARCH FOUNDATION   (India)

^b MEDICAL RESEARCH FOUNDATION   (India)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Eales disease; PEDF; Proliferative diabetic retinopathy; Ratio; VEGF

Indexed keywords

PIGMENT EPITHELIUM DERIVED FACTOR; VASCULOTROPIN;

ADULT; ANGIOGENESIS; ARTICLE; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETIC RETINOPATHY; EALES DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIRETINAL MEMBRANE; FEMALE; GROUPS BY AGE; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; NEOVASCULARIZATION (PATHOLOGY); ONSET AGE; OPHTHALMOSCOPY; PRIORITY JOURNAL; RETINA MACULA HOLE; VITREOUS BODY; WESTERN BLOTTING;

EID: 67651213638     PISSN: None     EISSN: 19368445     Source Type: Journal    
DOI: 10.1007/s12177-009-9022-x     Document Type: Erratum

References (31)

1. J Biswas T Sharma L Gopal 2002 Eales' Disease Surv Ophthalmol 47 197 214
2. S Ramakrishnan M Rajesh KN Sulochana 2007 Eales' disease: Oxidant stress and weak antioxidant defence Indian J Ophthalmol 55 95 102
3. Gieser SC, Murphy RP. Eales' disease. In: Ryan SJ, editor. Retina Vol II. Medical Retina. St. Louis: CV Mosby; 1994. p. 1503-7.
4. T Das J Biswas A Kumar 1994 Eales' disease Indian J Ophthalmol 42 3 18
5. S Saxena D Kumar 2004 A new staging system of idiopathic retinal periphlebitis Eur J Ophthalmol 14 236 239
6. M Rajesh KN Sulochana R Punitham S Lakshmi S Ramakrishnan 2003 Involvement of oxidative and nitrosative stress in promoting retinal vacuities in patients with Eales' disease Clin. Biochem 36 5 377 385
7. M Rajesh KN Sulochana K Coral 2004 etermination of carbonyl groups content in plasma proteins as a useful marker for assessing the impairment in antioxidant defense in patients' with eales' disease Indian J Ophthalmol 52 139 144
8. M Rajesh KN Sulochana S Ramakrishnan J Biswas PT Manoharan 2004 Iron chelation abrogates excessive formation of hydroxyl radicals and lipid peroxidation products in monocytes of patients' with Eales' disease: direct evidence using electron spin resonance spectroscopy Curr Eye Res 28 6 399 407
9. LP Aiello RL Avery PG Arrigg 1994 Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders N Engl J Med 331 1480 1487
10. N Ogata J Tombran-tink M Nishikawa 2001 Pigment epithelium-derived factor in the vitreous is low in diabetic retinopathy and high in rhegmatogenous retinal detachment Am J Opthalmol 132 378 382
11. BO Boehm G Lang O Volpert 2003 Low content of the natural ocular anti-angiogenic agent pigment epithelium-derived factor (PEDF) in aqueous humor predicts progression of diabetic retinopathy Diabetologia 46 394 400 (Pubitemid 36547595)
12. AC Ho DR Guyer SL Fine 1998 Macular hole Surv Ophthalmol 42 393 416
13. E Ezra 2001 Idiopathic full thickness macular hole: natural history and pathogenesis Br J Ophthalmol 85 102 108
14. S Ishida T Usui K Yamashiro 2003 VEGF164 is proinflammatory in the diabetic retina Invest Ophthalmol Vis Sci 44 2155 2162
15. N Ogata M Wada T Otsuji N Jo J Tombran-Tink M Matsumura 2002 Expression of pigment epithelium-derived factor in normal adult rat eye and experimental choroidal neovascularization Invest Ophthalmol Vis Sci 43 1168 1175 (Pubitemid 34258289)
16. S Yamagishi H Yonekura Y Yamamoto K Katsuno F Sato I Mita 1997 Advanced glycation end products-driven angiogenesis in vitro induction of the growth and tube formation of human microvascular endothelial cells through autocrine vascular endothelial growth factor J Biol Chem 272 8723 8730
17. Y Kaji T Usui S Ishida 2007 Inhibition of Diabetic Leukostasis and Blood-Retinal Barrier Breakdown with a Soluble Form of a Receptor for Advanced Glycation End Products Invest Ophthalmol Vis Sci 48 858 865
18. JI Patel J Tombran-Tink PG Hykin 2006 Vitreous and aqueous concentrations of proangiogenic, antiangiogenic factors and other cytokines in diabetic retinopathy patients with macular edema: Implications for structural differences in macular profiles Exp Eye Res 82 798 806
19. A Kumar S Sinha 2007 Rapid regression of disc and retinal neovascularization in a case of Eales disease after intravitreal bevacizumab Can J Ophthalmol 42 335 336
20. E Carrasco CH Andez A Miralles 2007 Lower somatostatin expression is an early event in diabetic retinopathy and is associated with retinal neurodegeneration Diabetes Care 30 2902 2908
21. Y Yoshida S Yamagishi T Matsui 2007 Positive correlation of pigment epithelium-derived factor and total antioxidant capacity in aqueous humour of patients with uveitis and proliferative diabetic retinopathy Br J Ophthalmol 91 1133 1134 (Pubitemid 47344883)
22. SX Zhang JJ Wang G Gao C Shao R Mott JX Ma 2006 Pigment epithelium-derived factor (PEDF) is an endogenous antiinflammatory factor FASEB J 20 323 325
23. KB Agnieszka HN Maria 2007 Influence of retinal photocoagulation in patients with proliferative diabetic retinopathy on vitreous vascular endothelial growth factor concentration Diabetologia 7 2 97 102
24. H Funatsu H Yamashita H Noma 2003 Outcome of vitreous surgery and the balance between vascular endothelial growth factor and endostatin Invest Ophthalmol Vis Sci 44 1042 1047 (Pubitemid 36297819)
25. S Swamy-Mruthinti KC Miriam S Krishnakumar 2002 Immunolocalization and quantification of advanced glycation end products in retinal neovascular membranes and serum: A possible role in ocular neovascularization Curr Eye Res 25 139 145
26. KN Sulochana K Coral R Punitham 2004 Trace elements iron, copper and zinc in vitreous of patients with various vitreoretinal diseases Indian J Opthalmol 52 145 148 (Pubitemid 38915503)
27. L Li G Renier 2006 Activation of nicotinamide adenine dinucleotide phosphate (reduced form) oxidase by advanced glycation end products links oxidative stress to altered retinal vascular endothelial growth factor expression Metabolism 55 1516 1523
28. S Yamagishi T Imaizumi 2005 Molecular mechanism of diabetic retinopathy: role of advanced glycation end products (AGEs) and their receptor (RAGE) in the pathogenesis of diabetic retinopathy Nippon Ganka Gakkai Zasshi 109 338 345
29. M Yokoi SI Yamagishi M Takeuchi 2005 Elevations of AGE and vascular endothelial growth factor with decreased total antioxidant status in the vitreous fluid of diabetic patients with retinopathy Br J Ophthalmol 89 673 675
30. W Saito S Hirose K Ohgami M Kase 2007 Positive association of pigment epithelium-derived factor (PEDF) with total anti-oxidant capacity in the vitreous fluid of patients with proliferative diabetic retinopathy Br J Ophthalmol 7 1 9
31. S Yamagishi K Nakamura T Matsui 2006 Pigment epithelium-derived factor (PEDF) inhibits advanced glycation end product-induced retinal vascular hyperpermeability by blocking reactive oxygen species-mediated vascular endothelial growth factor (VEGF) expression J Biol Chem 281 20213 20220